NEWS

/ NEWS / Axim Biotechnologies Goes With Grayling

Latest news from Grayling

Axim Biotechnologies Goes With Grayling

7th November 2016


Innovative biotechnology company, Axim Biotechnologies Inc has appointed Grayling in the US to support its Investor Relations and Public Relations’ needs.

Axim Biotechnologies is engaged in the research and development, and production of pharmaceutical, nutriceutical and cosmetic products, as well as the procurement of genetically and nano-controlled active ingredients. The company’s particular focus is on the development of treatments for pain, spasticity, anxiety and other medical disorders using cannabinoids-based products. Pharmaceutical R&D aims to deliver systems and active pharmaceutical ingredients for treating conditions such as Parkinson's disease, Alzheimer's disease, restless leg syndrome and Crohn's disease.

Presently, the company is conducting clinical studies of MedChewRx, a pharmaceutical chewing gum containing cannabinoids. The company is in the process of getting FDA and EMA regulatory approval to launch this product in 2017, and it is in regard to this that Grayling is providing support.

Grayling’s efforts will be driven by New York based executive vice president, Lucia Domville. She says: “This is a fascinating company that is really pushing the boundaries with its research, and we are thrilled to be their partner.”


Grayling Team

Latest News

11th June 2019


NGOs are welcome to join „Grayling 2020Challenge“

To celebrate its 20th anniversary in Slovakia, Grayling has decided to share its experience contributing to the visibility of projects that are changing Slovakia for the better. In collaboration with...

Read More

10th June 2019


Grayling spearheads PR industry campaign to enhance evaluation

Grayling is taking part in a new initiative to raise the standard of measurement and evaluation throughout the PR world. The Association for the Measurement and Evaluation of Communication (AMEC)...

Read More

23rd May 2019


SABRE Awards EMEA 2019: Grayling wins Public Affairs Consultancy of the Year

Grayling was named Public Affairs Consultancy of the Year at the SABRE Awards EMEA 2019 gala event in London. The international network, with 31 offices across 22 European countries, was honoured for...

Read More